Comparing blood levels of IX-01 when taken as a liquid or capsules,v 1

• Research type

  Research Study

• Full title

  A randomised, single-dose, 3-way crossover study to evaluate the relative bioavailability of the IX-01 capsule formulation compared with the IX-01 aqueous dispersion formulation, and the effect of food on the IX-01 capsule formulation, in healthy male subjects (HMR code: 13-013)

• IRAS ID

  152233

• Contact name

  Frans van den Berg

• Contact email

  fvandenberg@hmrlondon.com

• Sponsor organisation

  Ixchelsis Ltd

• Eudract number

  2014-000807-28

• Clinicaltrials.gov Identifier

  NCT02139826

• REC name

  Scotland A REC

• REC reference

  14/SS/0025

• Date of REC Opinion

  31 Mar 2014

• REC opinion

  Favourable Opinion